Precision Biosciences DTIL
NASDAQ DTIL
$9.15 -0.35 (-3.68%)
At close: Nov 11, 2026 · 4:00 PM EST

Precision Biosciences (DTIL) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

Precision Biosciences' Return on Capital Employed [ROCE] was -31.47% in fiscal Q3 2026 (quarter ended Sep 30, 2026), up 72.33 percentage points from -103.80% a year earlier but down 2.99 percentage points from the prior quarter.

Analysis

Precision Biosciences (DTIL) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025 (ended Dec 31, 2025), Return on Capital Employed [ROCE] at Precision Biosciences came in at -38.21%, down 18.55 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of +35.08 percentage points (FY2020 to FY2025).
  • In earlier fiscal years, Return on Capital Employed [ROCE] was -19.66% in FY2024 (+9.70 pp), -29.36% in FY2023 (+8.37 pp), -37.72% in FY2022 (-10.54 pp) and -27.18% in FY2021 (+46.10 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -103.80% (fiscal Q3 2025) and -5.13% (fiscal Q2 2024) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has increased for three straight quarters, with an average year-over-year change of -6.62 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was fiscal Q4 2021 (a gain of 72.72 percentage points); the worst was fiscal Q3 2025 (a drop of 92.82 percentage points).
  • Per Business Quant data, DTIL's Return on Capital Employed [ROCE] in the three fiscal quarters before Q3 2026 was -28.49% (Q2 2026), -27.66% (Q1 2026) and -45.33% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Precision Biosciences 264.98 Mn -121.18 Mn - -31.47%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -31.47%
Jun 30, 2026 -28.49%
Mar 31, 2026 -27.66%
Dec 31, 2025 -45.33%
Sep 30, 2025 -103.80%
Jun 30, 2025 -87.40%
Mar 31, 2025 -37.36%
Dec 31, 2024 -20.15%
Sep 30, 2024 -10.98%
Jun 30, 2024 -5.13%
Mar 31, 2024 -24.88%
Dec 31, 2023 -39.02%
Sep 30, 2023 -33.46%
Jun 30, 2023 -31.65%
Mar 31, 2023 -39.94%
Dec 31, 2022 -42.85%
Sep 30, 2022 -45.81%
Jun 30, 2022 -53.50%
Mar 31, 2022 -28.67%
Dec 31, 2021 -21.47%
API Access

Precision Biosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DTIL&period=max&api_key=YOUR_API_KEY